➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Boehringer Ingelheim
Merck
Mallinckrodt
Colorcon

Last Updated: February 26, 2021

DrugPatentWatch Database Preview

Torrent Pharms Ltd Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for TORRENT PHARMS LTD, and what generic and branded alternatives to TORRENT PHARMS LTD drugs are available?

TORRENT PHARMS LTD has twelve approved drugs.

There are five tentative approvals on TORRENT PHARMS LTD drugs.

Summary for Torrent Pharms Ltd
US Patents:0
Tradenames:11
Ingredients:11
NDAs:12

Drugs and US Patents for Torrent Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Torrent Pharms Ltd FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 202170-002 Nov 28, 2011 AB RX No No   Start Trial   Start Trial
Torrent Pharms Ltd QUETIAPINE FUMARATE quetiapine fumarate TABLET;ORAL 200363-002 Mar 27, 2012 DISCN No No   Start Trial   Start Trial
Torrent Pharms Ltd OLANZAPINE olanzapine TABLET;ORAL 091434-006 Apr 23, 2012 DISCN No No   Start Trial   Start Trial
Torrent Pharms Ltd ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 090939-003 Sep 11, 2012 AB RX No No   Start Trial   Start Trial
Torrent Pharms Ltd ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 090939-002 Sep 11, 2012 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Dow
Johnson and Johnson
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.